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A CLINICAL STUDY ON MANAGEMENT OF POSTOPERATIVE PAIN AND QUALITY 
OF LIFE OF OSTEOARTHRITIS PATIENTS AFTER TOTAL KNEE ARTHROPLASTY 
ABSTRACT 
Aim: To assess the management of postoperative pain and the Quality of Life of 
osteoarthritis patients after total knee arthroplasty.  
Methods: This Prospective observational study was conducted in the Department of 
Orthopaedics. Totally 96 patients were divided in to two groups. Group A consist 50 
patients with the treatment of NSAIDs and Group B consist 46 patients with the 
treatment of Pregabalin with NSAIDs. The pain scores were evaluated baseline, first 
and second follow up using VAS. Knee injury and Osteoarthritis Outcome Score 
questionnaire were used to assess pain, symptoms, ADL, SRF and QOL of 
Osteoarthritis patients after TKA. The study subjects were followed once in 30 days for 
3 months and they were asked to answer the same questionnaire. The effect of the 
treatment was assessed by comparing the baseline score with follow up score. All 
results were analysed using computerized statistical package of graph Pad instat 
Version 3.10.  
Results: Our study result shows that the pain relief in Group B  in VAS at second follow 
up   2.56 ± 0.34 and KOOS score at second follow up of Pain 92.73 ± 3.45, Symptoms 
89.23 ± 3.59, Activities of daily living 94.97 ± 2.71, and quality of life 81.56 ± 5.29 was 
improved and statistically significant when compared to Group A . The mean difference 
of second follow up Sport and recreation function 92.60 ± 2.52 was not statistically 
significant. (p < 0.01) 
Conclusion: The study concluded that pregabalin with NSAIDs group patient showed 
the better improvement in symptoms, activities of daily living and quality of life within 
short duration as compared to NSAIDS used patients. Regular patient counselling, 
maintenance of diet and exercise with good patient compliance may improve the quality 
of life of patients in day to day activities.   
Key words: Osteoarthritis, Total knee arthroplasty, Pregabalin, NSAIDs. 
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1. INTRODUCTION 
Osteoarthritis is a common, progressive disorder affecting primarily weight 
bearing diarthrodial joints, characterized by progressive deterioration and loss of 
articular cartilage, osteophyte formation, pain, limitation of motion, deformity and 
disability.1 Osteoarthritis is one of the most prevalent condition resulting to disability 
particularly in elderly patients.2 An estimated 10% to 15% of all adults over 60 have 
some degree of OA, with prevalence higher than men. 
  The Prevalence of OA is increasing due to population ageing and an increase in 
related factors such as obesity. According to the United Nations, by 2050 people aged 
over 60 will account for more than 20% of the world’s population. Of that 20%, a 
conservative estimate of 15% will have symptomatic OA, and one third of these people 
will be severely disabled. This means that by 2050, 130 million people will suffer from 
OA worldwide, of whom 40 million will be severely disabled by the disease.3 
About 13% of women and 10% of men aged 60 years and older have 
symptomatic knee OA. The proportions of people affected with symptomatic knee OA is 
likely to increase due to the aging of the population and rate off obesity or overweight in 
the general population. Prevalence of knee OA in men is lower compared with women. 
This was shown in a meta-analysis of males and females in which the incidence of knee 
OA in males and females aged < 55 years was lower than females. Females particularly 
those ≥55 years, tended to have more severe OA in the knee but not in other sites. The 
results of this study demonstrated sex differences incidence of knee OA particularly 
after menopausal age. In prospective study in which data where provided by 
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radiographs, physical performance assessment and interviews in 1996 and again in the 
follow up visits. Middle aged women had a high prevalence of moderate to severe knee 
osteoarthritis. The prevalence rates of knee OA vary according to study population s 
well s the methods applied for diagnosis. The prevalence rate was significantly with age. 
Symptomatic knee OA was significantly more common in rural compared to urban and 
suburban populations.2 
1.1.2 EPIDEMIOLOGY 
 Global statistics reveal over 100 million people worldwide suffer from OA, which 
is one of the most common cause of disability. In addition, younger individuals may be 
susceptible to injury induced OA. More than 50% of the populations around the world 
show X- ray evidence of OA in one of the joints, thus demonstrating the high incidence 
of this disease. As per a recent report published in the Times of India (2010) regarding 
OA, over 40% of the Indian population in the age group of 70 years or above suffer from 
OA. Nearly 2% of these undergo severe knee pain and disability.  
As per a recent statement quoted by Piramal healthcare limited in a nationwide 
campaign against chronic diseases, “India is expected to be the chronic disease capital, 
with 60 million people with arthritis, by 2025. Currently 80% of the persons affected by 
OA already report having some movement limitation, and 20% report not being able to 
perform major activities of daily living; with an 11% of the total population reporting the 
need of personal care.4 
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1.1.3 ETIOLOGY 
   Osteoarthritis has multifactorial etiologies, which occurs due to interplay 
between systemic and local factors. The etiology of this debilitating disease in which 
several responsible genes are linked for its occurance. Sports participation, injury to the 
joint, obesity and genetic susceptibility predispose adolescent athletes to the development 
of premature osteoarthritis. Old age female gender, overweight and obesity, knee injury, 
repetitive use of joints, bone density, muscle weakness and join laxity all play roles in the 
development of joint OA.2 
Primary Osteoarthritis: 
  Primary Osteoarthritis is a chronic degenerative disorder related to but not 
caused by aging. The pathophysiology of osteoarthritis involves a combination of 
mechanical, cellular and bio chemical processes. The interaction of these process leads 
to changes in the composition and mechanical properties of the articular cartilage. 
Cartilage is compose of water, collagen and proteoglycans. As a person ages, the water 
content of the cartilage decreases as a result of a reduced proteoglycan content, thus 
causing the cartilage to be less resilient. Without the protective effects of the 
proteoglycans, the collagen fibers of the cartilage can become susceptible to 
degradation and thus exacerbate the degeneration. Inflammation of the surrounding 
joint capsule can also occur, through often mid (compared to what occurs in rheumatoid 
arthritis). This can happened has breakdown products from the cartilage are released in 
to the synovial space, and the cells lining the joint attempt to remove them. New bone 
formation, called “Spurs” or osteophytes, can form on the margins of the joints, possibly 
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in an attempt to improve the congruence of the articular cartilage surfaces. These bone 
changes, together with the inflammation, can be both painful and disabling.6 
Secondary Osteoarthritis 
 This type of OA is caused by other factors but the resulting pathology is the same 
as for primary OA. 
 Congenital or developmental disorders of joints 
 Mechanical :  
Limp length discrepancy, malalignment, hyper- laxity, Ehlers –
Danlossyndrome, Marfan’s syndrome 
 Inflammatory: 
Rheumatologic diseases, i.e., Rheumatoid arthritis, SLE, all chronic forms 
of arthritis. 
 Traumatic:  
Injury to joints or ligaments, post – surgical. 
 Infective: 
Septic arthritis, Lyme disease 
 Metabolic : 
Haemochromatosis and Wilson’s disease, Gout, Calcium crystal 
deposition, alkaptonuria 
 Endocrine: 
Diabetes, Acromegaly, Hypothyroidism, Obesity. 
 Neuropathic arthopathy 
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 Miscellaneous: 
Haemophilia, Osteonecrosis.6 
1.1.4 RISKFACTORS 
There are many factors that can increase the risk of osteoarthritis and it’s often 
combination of these that leads to the condition. 
Age:  
  Osteoarthritis usually starts from the late 40’s onwards. We don’t fully 
understand why it’s more common in old people, but it might be due to factors like 
weakening of the muscle, but body being less able to heal itself or gradual wearing out 
of the joint with time. 
 Gender: 
  Osteoarthritis of the knee is twice as common in women as in men. It’s 
most common in women over the age of 50, although there’s no strong evidence that 
it’s directly linked to the menopause. It’s often associated with mild arthritis of the joints t 
the ends of the fingers, which is also more common in women. 
 Obesity: 
  Being overweight is an important factor in causing osteoarthritis, 
especially in the knee. It also increases the chances of osteoarthritis becoming 
progressively worse. 
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 Joint Injury: 
  Normal activity and exercise don’t cause osteoarthritis, but very hard, 
repetitive activity or physically demanding jobs can increase the risk. Injuries to the knee 
often lead to osteoarthritis in later life. A common cause is a torn meniscus or ligament, 
which can result from a twisting injury. A torn meniscus is common injury in footballers 
and an operation to remove the damaged cartilage or repair cruciate ligaments also 
increases the risk of osteoarthritis in later life. 
 Genetic factors: 
  Genetic factors play a major part in osteoarthritis of the knee. If you have 
a parent, brother or sister with knee osteoarthritis then you’ll have a greater chance of 
developing it yourself. We don’t know a lot about the genes that cause the increased 
risk, but we do know that a number of genes will have a small effect rather than one 
particular gene being responsible. 
 Other type of joint disease: 
  Sometimes osteoarthritis is a result of damage from different kinds of 
rather joint disease, such as gout, that occurred in earlier years.  
  Although there’s no evidence that different conditions such as cold or wet 
weather actually cause or worsen osteoarthritis, many people find that their pain and 
stiffness may be because nerve fibers in the capsule of affected joints are sensitive to 
changes in atmospheric pressure.7 
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Fig. 1. Schematic diagram of risk factors for Osteoarthritis 5 
1.1.5 PATHOPHYSIOLOGY: 
 Osteoarthritis is usually begins with damage to articular cartilage through injury 
excessive joint loading from obesity or other reasons or joint instability or injury. 
 Damage to articular cartilage increases activity of chondrocytes in attempt to 
repair damage, leading to increased synthesis of matrix constituents with cartilage 
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swelling. Normal balance between cartilage breakdown and resynthesis is lost, with 
increasing destruction and cartilage loss. 
 Subchondral bone adjacent to articular cartilage undergoes pathologic changes 
and releases vasoactive peptides and metallopepteinases (MMPs). Neovascularization 
and increased permeability of adjacent cartilage occur, which contribute to cartilage loss 
and chondrocyte apoptosis. 
 Cartilage loss causes joint space narrowing and painful, deformed joints. 
Remaining cartilage softens and develops fibrillations, followed by further cartilage loss 
and exposure of underlying bone. New bone formations at joint margins distant from 
cartilage destruction are thought to help stabilize affected joints. 
 Inflammatory changes can occur in the joint capsule and synovium. Crystals or 
cartilage shards in synovial fluid may contribute to inflammation.        Interleukin –1, 
prostaglandin E2, tumor necrosis factor – α (TNF- α) and nitric oxide in synovial fluid 
may also play a role. Inflammatory changes result in synovial effusions and thickening. 
 Pain may result from distension of the synovial capsule by increased joint fluid, 
micro fracture, periosteal irritation, or damage to ligaments, synovium or the meniscus. 1 
1.1.6 DIAGNOSIS  
 The diagnosis of Osteoarthritis is made with reasonable certainly based on the 
patient’s history, nature and severity of pain. It can also be diagnosed to measure the 
amount of movement in the joint.  X- Rays may confirm the diagnosis. An X – ray of the 
knee narrowing of the joint space is a good indicator of OA. The main characteristics of 
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OA are changes in the subchondral bone. The radiographic hall marks of primary OA 
include asymmetrical joint space narrowing or loss, subchondral sclerosis (increased 
bone formation around the joint), subchondral cyst formation and osteophytes. The 
initial radiographs may not show all of the findings. However, in early OA, minimal no 
uniform joint space narrowing may be the only radiographic finding. 
               
                  Figure 2: Radiographic findings of before and after TKA 
In some cases, for further clarity and better diagnosis the Magnetic resonance 
imaging (MRI) scan may be necessary. This allows the clinician to see whether any 
damage to the soft tissue has taken place within the joint.  
In certain cases, a blood sample like Normal Erythrocyte Sedimentation Rate 
(ESR) may be necessary to rule out the presence of other types of arthritis. 
For knee OA, patient must have knee pain and radiographic osteophytes in 
addition to one more of the following: 
1. Age more than 40 years 
2. Morning stiffness lasting 30 min or less 
3. Crepitus on motion 
4. Bony enlargement  
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5. Bony tenderness  
6. Palpable joint warmth 1, 4,6 
1.1.7 TREATMENT  
 NON PHARMACOLOGICAL TREATMENT: 
  Currently different non pharmacological treatments are available for cur of 
osteoarthritis. Weight reduction is one of the first and unproblematic measures that can 
be taken to reduce knee osteoarthritis 
  Educate patient about disease process and extent, prognosis and 
treatment. Promote dietary counseling, exercise and weight loss program for overweight 
patients. 
  Cold and heat treatments and an exercise program helps maintain range 
of motion and reduce pain and need for analgesics. 
  Assistive and orthotic devices (canes, walkers, braces, heel cups, insoles) 
can be used during exercise or daily activities. 
  Surgical procedures (e.g. Osteotomy, arthroplasty, joint fusion) are 
indicated for functional disability and severe pain unresponsive to conservative 
therapy.1 
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PHARMACOLOGICAL THERAPY 
  Treatment goals for the management of Osteoarthritis to reduce pain, 
stiffness, and maintenance or improving function of the knee, retarding the disease 
progression of joint damage and improvement of Quality of life.     
A range of oral analgesics, topical treatments and intra articular injections 
can be used to reduce pain and improve function in patients can be used to reduce 
pain and improve function in patients with osteoarthritis of the hip and knee.  
The American college of Rheumatology (ACR) has issued the guidelines for 
pharmacological treatment of osteoarthritis of the hand, hip and knee. For knee OA, 
the ACR conditionally recommends using one of the following 
1. Acetaminophen / Paracetamol 
2. Oral NSAID’s 
3. Topical NSAID’s 
4. Tramadol 
5. Intra- articular corticosteroid injections. 
The American College of Rheumatology (ACR) conditionally recommends 
against using chondroitin sulfate, Glucosamine or topical capsaicin for knee 
osteoarthritis. The ACR has no recommendations regarding the use of intra- articular 
hyaluronates, duloxine and opioid analgesics.1, 8 
Acetaminophen, aspirin and Non-steroidal anti-inflammatory drugs (NSAID’s) are 
commonly used as pain relief medicines to treat OA. Excessive use of NSAID’s can 
lead to gastric complications, ulcers increased risk for hospitalization, adverse effects 
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and death. Glucosamine and chondroitin sulfate are two nutritional supplements that 
have been reported to cure arthritis. As glucosamine and chondroitin are produced with 
in the body and are used inn repair of cartilage. 
Intra – articular hyaluronic acid as a long history of injections in to the joints f 
arthritic animals to improve their performance (therapy is called as 
“viscosupplementation”). Hyaluronic acid is a lubricating substance with in the joint 
which may be lost during osteoarthritis. It has been approved by US food and Drug 
Administration as a device for the treatment of OA in humans in 1997 although thought 
to have worked with arthritis, it was found that intra articular hyaluronic acid at best has 
a small effect in the treatment of knee osteoarthritis compared with an intra- articular 
placebo. 
The use of opioids should be limited to the patients who have contraindications 
or have ineffective response to acetaminophen and NSAID’s. Tramadol is the most 
commonly used agent alone or in combination for the treatment of moderate to severe 
Osteoarthritic pain. Codeine is also effective for Osteoarthritic pain. Opioids can cause 
hyper somnolence, constipation and rarely delirium – especially in the older patients. 
Therefore close monitoring is required when using these agents. Non tramadol opioids 
should not be routinely used, even if osteoarthritic pain is severe due to risk of adverse 
events.4,6 
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Topical creams: 
  Topical creams are used as adjuvant therapy. It is substitute 
therapy for oral medications for osteoarthritic pain. Topical medications like balms, 
creams, oils, gels, patches, solution forms – lotions, ointments. Most are available in 
OTC medications. Commonly DICLOFENAC is mostly used topical NSAID’s 
preparation. Dry skin is most common adverse effects. Topical CAPSAICIN is effective 
t 0.025% four times a day or 0.075% twice a dayfor OA pain. 
OTC topical pain medications are:  
 Counter irritants – contain menthol, eucalyptus oil, or oil of wintergreen 
and work by irritating the skin where it is applied. 
 Salicylates – are the main ingredients in topical analgesics. Creams 
which contain salicylates offer pain relief and reduce joint inflammation.6. 
Other drugs: 
Glucosamine: Glucosamine and chondroitin are members of a group of dietary 
supplements often termed “complementary agents”,     “disease – modifying agents” or 
“disease modifying osteoarthritis drugs” (DMOADs). They are derived from animal 
cartilage or crab shells. They relieve knee pain and perhaps repair the cells that line the 
joint. The effect is possibly the result of its anti-inflammatory activity, synthesis of 
proteoglycans, and inhibition of the synthesis of proteolytic enzymes. It also stimulates 
synovial production of hyaluronic acid.6 
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Diacerein: An oral interleukin - 1α inhibitor is reported to have slow acting, but 
persistent, symptomatic relief in patients with osteoarthritis.Diaceretin treatment of OA 
showed that it may be an alternative therapy for OA in patients who cannot take 
paracetamol or NSAID’s because of adverse effects or lack of benefit. Diarrhea is the 
most common side effect.   
Good pain control after surgery is important to prevent negative outcomes such as 
tachycardia, hypertension, myocardial ischemia and decrease in alveolar ventilation, poor 
wound healing and insomnia. Pain has been found to be one of the three most common 
medical causes of delayed discharge of after ambulatory surgery, the other two being 
drowsiness and nausea/ vomiting.9 
 Total Knee Arthroplasty (TKA) is an effective treatment for end stage knee 
osteoarthritis, but the optimal management of postoperative pain remains controversial. 
TKA is often cited as one of the most painful known procedures. Approximately 20% of 
the patients with OA of the knee do not want to undergo TKA because of the expectancy 
of high levels of pain. After total knee arthroplasty, the pain may also inhibit early 
rehabilitation to mobilize the knee joint.  
Different types of local anesthetic application can successfully treat TKA pain in 
older days. Although opioids can continuous epidural analgesia remain the major options 
for the postoperative pain management of TKA, they have some undesirable side effects. 
Epidural analgesia is technically demanding, and the patients require close monitoring 
after the surgery because complications such as hypotension, nausea and vomiting. The 
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administration of opioids do not consistently provide adequate pain relief and often cause 
sedation, confusion, and delirium, constipation, nausea, vomiting and pruritus.  
Epidural infusions containing local anesthetics (with or without an opioid) provide 
superior analgesics but are associated with hypotension, urinary retention, motor block 
limiting ambulation and spinal hematoma secondary to anticoagulation. In general, 
patients undergoing TKA are aged over 55 yrs and most often have accompanying health 
problems such as, diabetes, hypertension, and cardiac diseases which restrict high 
dosage opioids use. Although the femoral nerve block is an alternative and effective 
treatment to reduce postoperative pain.10, 11. 
NSAID’s are often considered to be the preferred first line treatment for OA. Use of 
non – opioid drugs during the preoperative period can reduce excess intra operative 
opioid use. The use of preoperative NSAIDs and COX – 2 inhibitors also has a significant 
effect on opioid requirements following surgery. This has been referred to as an “opioid 
sparing effect”. The clinical significance of this may be the reduction of opioid related side 
effects, improved analgesia and better patient satisfaction. The primary site of action of 
NSAIDs and COX – 2 inhibitors are in the periphery where they inhibit prostaglandin 
synthesis and stimulation of nociceptors. 
In addition of NSAIDs and COX – 2 inhibitors, anti neuropathic drugs as playing a 
role in the treatment of postoperative pain. Such drugs as gabapentin and pregabalin, 
intended for seizures and neuropathic pain syndromes, can inhibit central neuronal 
sensitization. Pregabalin was also found to have a synergistic effect with COX – 
2ninhibitors in clinical studies involving patient undergoing spinal fusion. The combination 
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of the two drugs reduced postoperative pain, morphine consumption at 24 hrs and opioid 
induced side effects. Improvements in outcome were greater when these drugs were 
used in combination than either of the drugs used alone.17. 
Acetaminophen is generally prescribed for treating the pain associated with OA. 
Tramadol also acts as a serotonin and norepinephrine reuptake inhibitor where it is 
essentially employed in OA to reduce the moderate to severe pain associated with the 
disease.180 
Osteoarthritis is a both inflammatory and neuropathic pain. Patients with 
neuropathic pain are challengeto manage. Pregabalin was developed for management of 
NP (Neuropathic pain).12The new pharmacological products to treat Postoperative pain 
management include extended release epidural morphine and analgesic adjuvants such 
as Capsaicin, Ketamin, Gabapentin,Pregabalin, dexmedetomidine and tapentadol.9 
Perioperative Pregabalin may reduce postoperative pain and opioid use. Among 
total knee arthroplasty patients, pregabalin 300 mg daily reduced acute pain, chronic pain 
and opioid use. A Meta-analysis found that pregabalin reduced postoperative pain and 
reduced analgesic drug intake, but only at doses ≥ 300mg daily.13 
Pregabalin is anα2δ ligand that modulates the activity of voltage gated calcium 
channels. In the US, pregabalin is indicated for the treatment of neuropathic pain 
associated with diabetic peripheral neuropathy with spinal cord injury, post therapeutic 
neuralgia, fibromyalgia and as adjunctive therapy for adult patients. In the European 
country, Pregabalin is indicated for peripheral and central neuropathic pain, epilepsy and 
generalized anxiety disorder. To further examine the safety and efficacy of pregabalin in 
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the postoperative setting, three separate, large, multicenter, randomized, placebo 
controlled trials of pregabalin as an adjunctive treatment for postoperative pain were 
conducted in patients following inguinal hernia repair (Post - IHR), following total knee 
arthroplasty (Post - TKA), following hysterectomy (Post hysterectomy).14 
 
1.2 DRUG MONOGRAPH 
                                       1.2.1 ACETAMINOPHEN 
Category/ class: 
 Analgesic and Antipyretic. 
Dose: 
 Osteoarthritis: 1000 mg orally 4 times daily for four weeks, total 4000 mg / 
day. 
 Pain : Mild to Moderate: 650 mg orally every 4 – 6 hours as needed. Max 
3250 mg / 24 hrs  
 Pain : Moderate to Svere: in combination with opioid medications: 50 
kg ≥ 1000mg IV every 6 hrs, 50 kg ≤ 15 mg/ kg IV every 6 hrs,  
Mechanism of Action: 
 Acetaminophen is a centrally acting analgesic and antipyretic with minimal 
anti – inflammatory properties. The mechanism of action of acetaminophen 
in reducing pain is unknown but may be due to an inhibition of central 
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prostaglandin synthesis (specifically cyclooxygenase (cox) – 2) and an 
elevation of the pain threshold. Acetaminophen reduces fever by inhibiting 
the formulation and release of Prostaglandins in the CNS and by inhibition 
endogenous pyrogens at the hypothalamic thermo regulator centre 
Adverse drug Reaction: 
 Common: 
 Dermatologic: Pruritis (5 % or greater) 
 Gastrointestinal: Constipation, Nausea, Vomiting 
 Neurologic: Headache, Insomnia 
 Psychiatric: Agitation 
 Respiratory: Atelectasis 
 
 Serious: 
 Dermatologic: Generalizedexanthematouspustulosis, acute 
Stevans – Johnson syndrome, toxic epidermal necrosis. 
 Hepatic: Liver failure 
 Respiratory: Pneumonitis 
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Indication: 
 FDA – Labeled indications: 
 Fever 
 Pain (mild to moderate) 
 Pain (moderate to severe), in combination with opioid 
medications 
 Non- FDA Labeled indications: 
 Migraine 
 Osteoarthritis 
 Vaccines adverse reaction; prophylaxis. 
Contraindication: 
 Acute and Severe hepatic disease 
 Hypersensitivity to acetaminophen or any other components of the 
product 
 Severe hepatic Impairment. 
Drug interaction: 
 Major: 
 Imatinib 
 Isoniazid 
 Pixantrone 
 Pneumococcal 13 – valent vaccine, Diphtheria conjugate 
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 Moderate: 
 Acenocoumarol 
 Carbamazepine 
 Fosphenytoin 
 Lixisenatide 
 Phenytoin 
 Warfarin 
 Zidovudine. 
Pregnancy Category:  
Category C. 
 
1.2.2 ACECLOFENAC 
Category/ class: 
 Non-steroidal Anti-inflammatory Drugs (NSAIDs). 
Dose: 
 Pain and inflammation in Rheumatoid arthritis, Osteoarthritis and 
Ankylosing spondylitis: 100 mg twice daily by orally.                                                          
Mechanism of Action: 
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 Aceclofenac, a phenylacetic acid derivative is a potent inhibitor of 
cyclooxygenase enzyme, involved in the production of prostaglandins, 
causing marked anti inflammatory and analgesic properties. 
 Absorption: 
 Rapidly and completely absorbed from the GI tract. Time to peak 
plasma concentration: 1-3 hr. 
 Distribution: 
 Penetrates into the synovial fluid. Volume of Distribution: approx: 25 
L. plasma protein binding: > 99% 
 Metabolism: 
 Metabolism into 4’-hydroxyaceclofenac 
 Excretion: 
 Via urine. Plasma elimination half- life : approx 4 hr. 
Adverse drug Reaction: 
 Alveolitis, Aseptic meningitis, Hepatic damage, Interstitial fibrosis 
associated with NSAIDs can lead to renal failure, Pancreatitis, Papillary 
necrosis associated with NSAIDs can lead to renal failure, Pulmonary 
eosinophilia, Stevans – Johnson syndrome, Toxic epidermal necrosis, 
visual disturbances. 
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Indication: 
 Pain and inflammation in Rheumatoid arthritis,  
 Osteoarthritis  
 Ankylosing spondylitis 
Contraindication: 
 Hypersensitivity to aceclofenac or other NSAIDs, ischemic heart disease, 
moderate to severe renal and severe hepatic impairment. 
Drug interaction: 
 Interacts with digoxin, lithium, methotrexate, cyclosporine, diuretics, 
phenytoin, warfarin. 
Pregnancy Category:  
 Category N (FDA has not yet classified the drug into a specified 
pregnancy category). 
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1.2.3 PREGABALIN 15, 16 
Category/ class: 
 Anxiolytics 
 Anticonvulsants 
 Neuropathic pain 
 Gamma aminobutyric Acid 
Dose: (from Beers criteria): 
 Diabetic Peripheral neuropathy – Neuropathic pain 
 Initial 50mg orally three times a day and max dose 100 mg 
orally three times a day. 
 Fibromyalgia 
 Initial 75 mg orally twice daily; may increase to 150 mg twice 
daily; max 225 mg twice daily. 
 Neuropathic Pain - Spinal cord injury 
 Initial 75 mg orally twice daily; may increase to 150 mg twice 
daily; may further increase to 300 mg orally twice daily for 
sufficient pain relief after 2 – 3 weeks of treatment. 
 Partial Seizure; Adjunct 
 Initial no greater than 75 mg orally two times daily or 50 mg 
orally three times daily; max dose of 600 mg / day in divided 
dose. 
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 Post therapeutic neuralgia 
 Initial 75 mg orally two times daily or 50 mg orally three 
times daily; may be increased to 300 mg/day. 
 Generalized anxiety disorder 
 300to 600 mg orally daily usually given in 3 divided doses. 
Or 150 to 600 mg orally daily. 
 Postoperative Pain 
 Optimal dosage has not been established, 150 mg to 600 
mg per day orally has been used in clinical trials or 150 to 
300 mg orally 2 hours period to surgery or 1 hour prior to 
induction of anesthesia. 
 Restless legs syndrome 
 300 mg orally once daily, given 1 to 3 hours before bed time.  
Mechanism of Action: 
 Pregabalin is an analogue of the neurotransmitter GABA. It binds potently 
to the α2δ submit resulting in modulation of Ca channels and reduction in 
the release of several neurotransmitters, including glutamate, 
norepinephrine, Serotonin, dopamine, calcitonin gene related peptide and 
substance P. 
 Absorption:   
 Rapidly absorbed. 
 Bio Availability: Approx. 90%.time to peak. 
 Plasma Concentration: W/ in 1.5 hr. 
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 Distribution: 
 Volume of distribution: 0.5 L/ Kg. Not bound to plasma protein. 
 Metabolism: 
 Negligible metabolism 
 Excretion: 
 Via urine (app. 98%) as unchanged drug. 
 Elimination half- life: 6.3 hr. 
Adverse drug Reaction: 
 Common 
 Cardiovascular: Peripheral edema 
 Endocrine metabolic: Increased Appetite, Weight gain  
 Gastrointestinal: Constipation, Xerostomia 
 Neurologic: Asthenia, Ataxia, Dizziness, Headache, Incoordination, 
Somnolence and Tremor. 
 Ophthalmic: Blurred vision, Diplopia. 
 Psychiatric: Disturbance in thinking, Euphoria 
 Respiratory:Nasopharyngitis. 
 Other: Fatigue. 
 Serious 
 Hepatic: Jaundice 
 Immunologic: Hypersensitivity reaction 
 Musculoskeletal: Increased creatine kinase level. 
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 Psychiatric: Suicidal thoughts. 
 Other: Angioedema. 
Indication: 
 FDA Labeled indication: 
 Diabetic Peripheral neuropathy – Neuropathic pain 
 Fibromyalgia 
  Neuropathic Pain - Spinal cord injury. 
  Partial Seizure; Adjunct 
 Post therapeutic neuralgia 
 Non FDA Labeled indications: 
 Generalized anxiety disorder 
 Postoperative Pain 
 Restless legs syndrome. 
Contraindication: 
 Contraindicated in patients with Hypersensitivity 
Drug interaction: 
 Calcifediol 
 Orlistat 
Pregnancy Category: Category C. 
 
Introduction 
 
A Clinical Study on Management of Postoperative Pain and Quality of Life of 
Osteoarthritis Patients After Total Knee Arthroplasty  Page 27 
 
     1.3 PAIN SCORES 
In this study, determine the efficiency of pain treatments and to compare the success 
rates between each group. 
  Visual Analogue Scale (VAS) 
  Knee Injury and Osteoarthritis Outcome Score (KOOS) 
1.3.1 VISUAL ANALOGUE SCALE (VAS) 
The visual analogue scale is undimensional measure of pain intensity, which has been 
widely used in diverse adult population including those with arthritic disease.19wherein 
zero denoted “no pain” and 10 mm denoted the “worst pain” at the end of painless time 
and 24 hr after the operation by VAS tables and follow up the every month up to 6 
months postoperatively.10 (Annexure V)
 
Figure 3: Visual Analogue Scale (VAS) 
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     1.3.2 KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE (KOOS) 
The knee injury and osteoarthritis outcome score is an extension of the Western Ontario 
and McMaster Universities Osteoarthritis Index (WOMAC). The KOOS reflects the 
increasingly younger and more active demographic of people undergoing Total Knee 
Artroplasty (TKA). The KOOS is a 42 – item self-report questionnaire that has 5 
reported dimensions: Pain (9 items), other Symptoms (7 items), Activities of Daily Living 
(ADL) (17 items), Sport and Recreation Function (SRF) (5 items), and knee related 
Quality of life (QOL) (4 items). The scoring system of the KOOS utilizes a 5 point likert 
scale, with anchors of zero (no problems) to 4 (extreme problems). Scores are 
transformed to a 0 to 100 scale with zero representing extreme knee problems and 100 
representing no knee problems.20 (Annexure VI) 
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2. LITERATURE REVIEW 
Fei Li et al., (2017) conducted a study to evaluate the efficacy of pregabalin for 
the management of postoperative pain in primary total knee and hip arthroplasty. A 
meta-analysis the results found to be postoperative side effects such as nausea, 
vomiting, pruritus and dizziness. When comparing the pregabalin group to be placebo 
group after TKA and THA. Concluded from this study was pregabalin improve pain 
control at  24 and 48 hrs with rest, reduce morphine consumption, improve the knee 
flexion degree, decrease the  incident rate of nausea, vomiting, and pruritus and 
increase the incident rate of dizziness after TKA and THA.21 
Chao Han et al., (2017) conducted a study to examine the evidence of 
pregabalin effectiveness and safety in total knee arthroplasty and concluded as the 
administration of pregabalin is not only efficacious in the reduction of narcotic 
requirements and incidence of some adverse effect, but also workable for the 
improvement of passive knee flexion range after TKA.22 
Yingdelong Mao et al., (2016) studied the efficacy of preoperative 
administration of gabapentin/ pregabalin in improving pain after total hip arthroplasty 
and concluded as gabapentin, or pregabalin can decrease the cumulative morphine 
consumption and decrease the occurrence of nausea however further trials are needed 
to assess the efficacy of pain control by gabapentin or pregabalin.23 
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Rajshree Mishra et al., (2016) studied is to evaluate postoperative analgesic 
benefit and efficacy in patients administered with oral gabapentin or pregabalin as 
premedication for laparoscopic cholecystectomy under general anesthesia, the patients 
were randomly allocated in three groups. Groups A, B, and C received 2 capsules of B 
complex, 3 capsules of 300 mg gabapentin each, and 2 capsules of 75 mg pregabalin, 
respectively, each in 30 patients of each group, 1 h before induction of anesthesia and 
concluded that pregabalin group had lower VAS score, prolonged timing of first rescue 
analgesic, and less opioids consumption than the gabapentin group. Both 
gabapentinoids had better postoperative analgesic profile than placebo.26 
Xu Jianda et al., (2016) to investigate the effects of preemptive analgesia on the 
inflammatory response and rehabilitation in TKA. 75 patients with unilateral primary 
knee osteoarthritis were conducted in this prospective study. All patients were randomly 
divided in to 2 groups MMA with/ without preemptive analgesia group as concluded 
preemptive analgesia added to multimodal analgesia regime improved analgesia, 
reduced inflammatory reaction and accelerated functional recovery at the first week 
postoperatively, but not improved long term function.24 
Dr. Keith holt et al., (2016)  studied pain management after knee replacement 
and says that the pregabalin is a pre-operative pain modifying agent and this is the most 
commonly used for post-operative pain. It’s most beneficial in the first 2 to 3 days. After 
that with someone exceptions it fails to reduce the dosage of other analgesics and now 
pregabalin may then prove very helpful.25 
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Neil K Singla et al., (2015) conducted a study on pregabalin for the treatment of 
postoperative pain: results from three controlled trials using different surgical models. 
Totally 3 categories of surgical procedures was done one category of Post TKA patients 
are selected in 307 patients were randomly selected to treatment and shows that there 
were no significant differences between pregabalin and placebo with respect the 
primary pain intensity measure in each of the three clinical trials. These study 
encompass a large dataset (1,233 patients in total) and their results should be 
considered when assessing pregabalin’s effectiveness in postoperative pain.14 
J. T. YaDeau et al., (2015) studied about the drug pregabalin and pain after total 
knee arthroplasty: a double-blind, randomized, placebo-controlled, multidose trial and 
concluded as the pregabalin had no beneficial effects, but increased sedation and 
decreased patient satisfaction and also this study does not support the routine 
perioperative pregabalin for total knee arthroplasty patients.27 
Sawan H et al., (2014) conducted a study on pregabalin reduces opiod 
consumption and improves pain after total knee arthroplasty, even in patients who are 
previous users of chronic pain medications shows that pregabalin in the context of 
multimodal pain management may be associated with reduced opiod consumption and 
other medical complications in patients undergoing TKA, including previous users of 
chronic pain medications.30 
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Seiji Ohtori et al., (2013) studied the efficacy of meloxicam and pregabalin for 
pain in knee osteoarthritis patients were divided in to 3 groups in to meloxicam, 
pregabalin and meloxicam+pregabalin groups and pain scores are evaluated before and 
after 4 weeks after drug application using Visual analogue scale and WOMAC and 
reveals that a combination of meloxicam plus pregabalin was effective for OA pain in 
OA patients. Furthermore, this study suggests that OA pain is a combination of 
inflammatory and neuropathic pain components.12 
Mohsen Mardani-Kivi et al., (2013) studied Celecoxib as a pre-emptive 
analgesia after arthroscopic knee surgery; a triple-blinded randomized controlled trial to 
examine the therapeutic effects of celecoxib in reducing pain following the arthroscopic 
knee surgeries: anterior cruciate ligament (ACL) reconstruction and partial 
meniscectomy and concluded that celecoxib as a pre-emptive analgesia agent is 
effective in decreasing acute postoperative pain and 24 h opioid consumption in 
patients undergoing arthroscopic knee surgery.29 
Hance Clarke et al., (2012) studied the prevention of chronic postsurgical pain 
using gabapentin and pregabalin: a combined systematic review and meta-analysis was 
concluded by the perioperative administration of gabapentin and pregabalin are 
effective in reducing the incidence of chronic postsurgical pain.34 
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S.Y. Kim et al., (2011) conducted Pregabalin reduces post-operative pain after 
mastectomy: a double-blind, randomized, placebo-controlled study says Pregabalin is 
used for the treatment of neuropathic pain and has shown analgesic efficacy in post-
operative pain and concluded that Perioperative administration of pregabalin for a single 
day (75 mg twice daily) was easy, safe and effective in reducing post-operative pain in 
patients undergoing mastectomy. 31 
Dalim Kumar Baidya et al., (2011) studied pregabalin in acute and chronic pain 
as concluded the pregabalin exhibits a significant opioid sparing effect in the first 24 
hour and a significant reduction in opioid – related adverse effects (vomiting). The 
incidence of visual disturbance is significant with pregabalin other side effects like 
sedation and dizziness are also increased. However, pregabalin 150 – 600 mg / day 
has a proven efficacy under chronic neuropathic pain conditions like painful diabetic 
neuropathy, post therapeutic neuralgia, central neuropathic pain and fibromyalgia. It 
may be more cost- effective than high dose gabapentin and may be effective in patients 
who have previously failed to respond to gabapentin.38 
 SS Harsoor et al., (2011) studied Emergency concepts in postoperative pain 
management as informed from this study pregabalin is known to produce analgesic, 
sedative and anti-anxiety properties. The reports about its role in acute pain 
management are equivocal, but its use in chronic pain is well established. The 
properties such as the absence of respiratory depression, gastric-sparing effects and 
anxiolysis make pregabalin a useful adjuvant even in the management of post-surgical 
pain, but probably larger studies may be needed before the drug is advocated for 
routine use.37 
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Spreng UJ et al., (2011) conducted a study on Effect of a single dose of 
pregabalin on post-operative pain and pre-operative anxiety in patients undergoing 
discectomy. A randomized, placebo-controlled study of 150 mg pregabalin administered 
before lumbar discectomy in general anesthesia and concluded A single dose of 
pregabalin (150 mg) reduced post-operative pain at rest and morphine consumption 
during the post-anesthetic care unit period after lumbar discectomy. Pre-operative 
anxiety was lower, without increased incidence of side effects. 35 
J. Zhang et al., (2011) studied Efficacy of pregabalin in acute postoperative pain: 
a meta-analysis and concluded that the perioperative administration of pregabalin has a 
significant opioid-sparing effect in the first 24 hr after surgery. Postoperative vomiting 
was reduced, whereas visual disturbance was more common with pregabalin 
administration. The efficacy of perioperative pregabalin in more painful procedures and 
on the prevention of chronic pain should be investigated in future studies.39 
 Asokumar Buvanendran et al., (2010) conducted a study on Perioperative oral 
pregabalin reduces chronic pain after total knee arthroplasty: a prospective, 
randomized, controlled trial. A randomized, placebo controlled , double blind trial was 
conducted 240 patients randomly assigned to the two groups were obtained from 113 
pregabalin patients an 115 placebo patients was concluded that perioperative 
pregabalin administration reduces the incidence of chronic neuropathic pain after total 
knee replacement, with less opioid consumption and better range of motion during the 
first 30 days of rehabilitation. In the doses tested it is associated with a higher risk of 
early postoperative sedation and confusion.40 
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 Nalini Vadivelu et al., (2010) studied Recent advances inn postoperative pain 
management says that recent years also have witnessed a heightened research interest 
in the analgesic, sedative, anxiolytic and opioid sparing effects of pregabalin, a 
structural analogue of GABA and derivative of gabapentin in various pain settings, 
including postoperative pain. Pregabalin has a e4stablished efficacy of varying degree 
in neuropathic pain conditions such as post therapeutic neuralgia, painful diabetic 
neuropathy, central neuropathic pain and fibromyalgia. While some studies do not 
demonstrate a significant analgesic effect in the acute, including postoperative pain 
scenario other studies suggest pregabalin to have effective sedative and opioid sparing 
effects useful characteristics for the control of acute pain.9  
Carlo Luca Romano et al., (2009) conducted a study on pregabalin, celecoxib 
and their combination for treatment of chronic low back pain a double blind, prospective 
study concluded that the combination of celecoxib and pregabalin is more effective than 
monotherapy for chronic low back pain, with similar adverse effects.43 
R Andrew Moore et al., (2009) conducted a study on Pregabalin for acute and 
chronic pain in adults. A Randomized, double blind trials reporting on the analgesic 
effect of pregabalin, with subjective pain assessment by the patient as either the 
primary or a secondary outcome and concluded that Pregabalin has proven efficacy in 
neuropathic pain conditions and fibromyalgia. A minority of patients will have substantial 
benefit with pregabalin, and more will have moderate benefit. Many will have no or trivial 
benefit, or will discontinue because of adverse events. Individualization of treatment is 
needed to maximize pain relief and minimize adverse events. There is no evidence to 
support the use of pregabalin in acute pain scenarios. 49 
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 Kishor Gandhi et al., (2009) studied multimodal pain management techniques in 
hip and knee arthroplasty. He says that multimodal approach to pain control involves 
administration of combination and often multiple analgesics or modalities at various time 
points during the course of surgery that includes preoperative period. Pain control after 
knee and hip arthroplasty can be achieved with the combination of drugs used during 
the preoperative , intra operative and the post-operative periods (NSAIDs, COX 2 
Inhibitors, α 2 agonist, NMDA antagonists, anti convulsants and centrally acting 
analgesics as acetaminophen) was concluded multi model analgesia offers many 
benefits to patients undergoing total joint arthroplasty. Opioids remain an integral part of 
most analgesic plans but techniques that reduce opioid requirements typically improve 
pain control both at rest and motion, reduce opioid relate3d side effects, provide better 
patient satisfaction and according to a recent study, may reduce the incidence of long 
term pain following surgery.17 
 Ittichaikulthol W et al., (2009) studied Effects of pregabalin on post-operative 
morphine consumption and pain after abdominal hysterectomy with/without salphingo-
oophorectomy: a randomized, double-blind trial and to evaluate the effect of 
premedication with pregabalin 300 mg compared with lorazepam 0.5 mg on post-
operative morphine consumption in women undergoing abdominal hysterectomy 
with/without salphingo-oophorectomy and concluded  A 300 mg pregabalin 
administered 1 hr preoperatively before abdominal hysterectomy with/without salphingo-
oophorectomy significantly reduced morphine consumption, VNRS pain score and 
improved satisfaction score at 24 hr post operatively without any significant differences 
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in side effects. Pregabalin is an alternative combination to opioids as multimodal 
analgesia.52 
Aditya V Maheshwari et al., (2009) conducted a study on Multimodal pain 
management after total hip and knee arthroplasty at the Ranawat Orthopedic Center as 
concluded Multimodal protocols after THA and TKA have been a substantial advance; 
they provide better pain control and patient satisfaction, lower overall narcotic 
consumption, reduce hospital stay and improve function while minimizing complications. 
Although no pain protocol is ideal, it is clear that patients should have optimum pain 
control after THA and TKA for enhanced satisfaction and function.42  
 O. Mathiesen et al., (2008) conducted a study on Pregabalin and 
dexamethasone for postoperative pain control: a randomized controlled study in hip 
arthroplasty. In this study total one hundred and twenty patients were randomly divided 
in to three groups in Group A (placebo) and Group B (pregabalin 300 mg) and Group C 
(pregabalin + dexamethasone 8 mg).  the medication and acetaminophen 1 g were 
given before operation and the results are 24 hr morphine consumption was significantly 
reduced in Group B and C compared with Group A. vomiting was reduced in Group C 
compared with Group B. sedation was significantly increased in Group B compared with 
the other groups and concluded from the study was Pregabalin resulted in a 50% 
reduction in 24 h postoperative morphine requirements. This was not associated with a 
reduced incidence of nausea or vomiting. Pregabalin resulted in increased levels of 
sedation. Combining pregabalin and dexamethasone provided no additional effects on 
pain or opioid requirements.44 
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Stefan Bergman et al., (2006) conducted Knee complaints vary with age and 
gender in the adult population. Population based reference data for the knee injury and 
Osteoarthritis Outcome Score (KOOS). The population based cohort study with Knee 
specific KOOS was done in 840 subjects aged 18 to 84 yr patients. Result was 68% 
response rate. Women in the age group 55 – 74 reported more knee related complaints 
in all the KOOS subscales than age matched men. The differences  were significant for 
the subscales pain, symptoms and ADL function. In men, worse ADL and sport and 
Recreation function was seen in the oldest age group 75 – 84 yrs compared to the 
younger age groups. In Women, worse pain, ADL, sport and recreation and QOL were 
seen already in the age group 55 – 74 compared to the younger age groups. The 
concluded pain and other symptoms, physical function and knee related quality of life to 
vary with age and gender implying the use of age and gender matched reference values 
for improved understanding of the outcome after interventions due to knee injury and 
knee OA.46 
Ewa M Roos et al., (2003) studied the knee injury and Osteoarthritis outcome 
score (KOOS): from joint injury to osteoarthritis was concluded KOOS was developed 
as an extension of the WOMAC Osteoarthritis index with the purpose of evaluating short 
and long term symptoms and function in young and physically active subjects with knee 
injury and OA. The questions of the WOMAC LK 3.0 were retained so that a WOMAC 
score might be calculated separately and compared with the KOOS score. As expected, 
larger effects sizes for KOOS as compared with WOMAC were shown for young 
subjects with knee injury.48    
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Asokumar Buvanendran et al., (2003) conducted a study on Effects of 
Perioperative Administration of a Selective Cyclooxygenase 2 Inhibitor on Pain 
Management and Recovery of Function after Knee Replacement a Randomized 
Controlled Trial and concluded Perioperative use of an inhibitor of cyclooxygenase 2 is 
an effective component of multimodal analgesia that reduces opioid consumption, pain, 
vomiting, and sleep disturbance, with improved knee range of motion after TKA.49 
 M. Hyllested et al., (2002) conducted a study on Comparative effect of 
paracetamol, NSAIDs or their combination in postoperative pain management: a 
qualitative review was perform a systematic, qualitative review of postoperative pain 
studies comparing paracetamol (min 1000 mg) with NSAID in a double- blind, 
randomized manner as concluded Paracetamol is a viable alternative to the NSAIDs, 
especially because of the low incidence of adverse effects, and should be the preferred 
choice in the high risk patients. It may be appropriate to combine paracetamol with 
NSAIDs, but future studies are required, especially after major surgery, with specific 
focus on a potential increase in side effects from their combined use. 54 
 C.M.Hill et al., (2001) conducted a study on Pregabalin in patients with 
postoperative dental pain A randomized, double-blind, placebo-controlled, parallel-
group trial was undertaken to compare pregabalin to placebo and 400 mg of ibuprofen 
using a dental pain model administered postoperatively to patients and concluded 
pregabalin group had a significantly longer duration of analgesia than the ibuprofen 
group and had the highest score on the patient global impression of study medication. 
Adverse events were reported more frequently in the pregabalin 300-mg group.62
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John D. Bradley et al., (1991) conducted a study on Comparison of an Anti-
inflammatory dose of ibuprofen, an analgesic dose of ibuprofen and acetaminophen in 
the treatment of patients with osteoarthritis of the knee. A randomized double blind trial, 
184 patients with chronic knee pain due to osteoarthritis were given either 2400 or 1200 
mg of ibuprofen per day or 4000 mg of acetaminophen per day and concluded 
symptomatic treatment of osteoarthritis of the knee, the efficacy of acetaminophen was 
similar to that of ibuprofen, whether the latter was administered in an analgesic or an 
anti-inflammatory dose.59      
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3. AIM AND OBJECTIVES 
3.1 Aim:-  
 To assess the management of postoperative pain and the Quality of Life of 
osteoarthritis patients after total knee arthroplasty. 
 
3.2 Objectives:- 
 To assess the effect of NSAID’s Vs Pregabalin with NSAIDs after total knee 
arthroplasty 
 To compare the Quality of Life of osteoarthritis patients after total knee 
arthroplasty 
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 4. PLAN OF STUDY  
This study was carried out a period from the month of November 2016 to October 2017. 
The proposed study has been designed below. 
 
 
 
 PHASE I 
 
 
 
            PHASE II      
      
      
       
 
 
 
 
PHASE III 
  
Identification of target area 
for possible research 
Literature review 
Preparation of study 
protocol 
Designing of Data entry 
form & Selection of 
Questionnaire 
Obtaining approval from 
ethical committee 
Obtaining consent from the 
Patient 
Data collection 
Analysis of Data 
Interpretation and 
Reporting the Results 
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5. METHODOLOGY 
5.1 STUDY DESIGN: 
 The study was a Prospective Observational study. 
5.2 STUDY SITE: 
  The study was carried out in the Department of Orthopedics at Vivekanandha 
Medical Care Hospital, Tiruchengode. 
5.3 DURATION OF THE STUDY: 
 The study was conducted from Nov 2016 to Oct 2017 in the Department of 
Orthopedics. 
5.4 INCLUSION CRITERIA: 
 Patient’s with 40 to 75 years of age 
 Both male and female patients 
 Patients with treatment of NSAID’s or Pregabalin with NSAID’s          
 Patients who underwent Total Knee Arthroplasty. 
5.5 EXCLUSION CRITERIA: 
 Allergy or intolerance to any of the study drugs  
 Severe liver failure and heart or renal failure patients. 
 Patient with history of opioid medication usage.  
 Patient with bleeding disorder  
Methodology 
 
A Clinical Study on Management of Postoperative Pain And Quality of Life of 
Osteoarthritis Patients After Total Knee Arthroplasty Page 44 
 
5.6 ETHICAL CLEARANCE: 
 The study was approved (Ref.No:SVCP/IEC/JAN/2016/12) by Institutional Ethical 
Committee of Vivekanandha Medical Care Hospital (Annexure - 1). 
5.7 STUDY POPULATION: 
  Total 245 patients medical and medication history were reviewed. From that 110 
patients were included in the study as per the inclusion and exclusion criteria. Out of 
which 14 patients were withdrawn from this study due to poor compliance and missed 
follow up. Totally 96 patients were completed the study.  
  Total no of patients screened 
                       (n = 245) 
 
Total no of patients included                                               Total no of patients excluded 
 (n = 110)                           (n = 135) 
 
Total no of patients Completed the study    Total no of patients withdrawn from the study      
(n = 96)       (n=14) 
 
Group A (NSAID’s)                          Group B (Pregabalin with NSAID’s) 
  (n = 50)                                                 (n = 46) 
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5.8 SOURCES OF DATA: 
 Patient case records. 
 Designed data entry form and pain questionnaire. 
 Medication charts and Lab reports and patient / patient care taker’s 
interview. 
 Visual analogue pain Scale and Knee injury and Osteoarthritis Outcome 
Score Pain questionnaire. 
5.9 METHOD OF STUDY: 
Patients were selected randomly to the study as per the inclusion and exclusion 
criteria. Selected patients were divided in to two groups. 
Group A consist 50 patients with the treatment of NSAIDs (Paracetamol 325 mg+ 
Aceclofenac 100 mg) and Group B consist 46 patients with the treatment of Pregabalin 
75 mg + NSAIDs (Paracetamol 325 mg + Aceclofenac 100 mg)  
The patient demographics data was collected by using data entry form. The 
baseline score of pain, symptoms, Activities of daily living, Sport and recreation function 
and quality of life assessed by using KNEE INJURY AND OSTEOARTHRITIS 
OUTCOME SCORE (KOOS) questionnaire, to enrolled subjects were asked to answer 
KOOS questionnaire and VISUAL ANALOGUE SCALE (VAS). 
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The initial score was considered as a baseline. The study subjects were followed 
once in 60 days for 6 months and they were asked to answer the same questionnaire. 
The effect of the treatment was assessed by comparing the baseline score with follow 
up score. 
The Quality of Life of the patient before and after the treatment was assessed by 
KOOS. 
 5.10 STATISTICAL ANALYSIS: 
 All results were analyzed using computerized statistical package of graph Pad 
instat Version 3.10. Values are represented as Mean ± SD (standard Deviation). Scores 
of KOOS Questionnaire and Visual Analogue Scale (VAS) were compared by using the 
Student’s t-test. P<0.05 was considered as statistically significant. 
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6. RESULTS 
A total of 96 Osteoarthritis patients after Total Knee Arthroplasty were selected 
as per inclusion and exclusion criteria. The demographic details, Visual Analogue pain 
scale score and pain scores (KOOS) were collected at baseline. The study subjects 
were followed once in 60 days for 6 months.  
6.1 AGE WISE DISTRIBUTION AMONG THE STUDY POPULATION 
  Among 96 patients, 9.40% (9) were in the age group of 40 – 49 years, 24 % (23) 
were in the age group of 50 – 59 years, 48 % (46) were in the age group of 60 – 69 
years, 18.75 % (18) were in the age group of 70 – 79 years. The mean age of the study 
population was 61.66 ± 7.56 years (range 40 - 79). (Table 1, Figure 4) 
Table 1:  AGE WISE DISTRIBUTION AMONG STUDY POPULATION (n = 96) 
S. No AGE (YEARS) NO OF PATIENT PERCENTAGE 
1.  40 – 49 09 09.40% 
2.  50 – 59 23 24.00% 
3.  60 – 69 46 48.00% 
4.  70 – 79 18 18.75% 
5.  Mean Age 61.66 ± 7.56 
 
 
 
 
 
       Figure 4: AGE WISE DISTRIBUTION AMONG STUDY POPULATION (n = 96) 
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6.2 GENDER WISE DISTRIBUTION AMONG STUDY POPULATION (n = 96) 
 A total of 96 osteoarthritis patients, males were 41.66% (40) and Females were 
58.34 % (56). (Table 2, Figure 5) 
Table 2: GENDER WISE DISTRIBUTION AMONG THE STUDY POPULATION 
 (n = 96) 
S. No GENDER NUMBER OF PATIENT PERCENTAGE 
1.  MALE 40 41.66% 
2.  FEMALE 56 58.34% 
 
 
 
Figure 5: GENDER WISE DISTRIBUTION AMONG THE STUDY POPULATION 
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6.3 BODY MASS INDEX (BMI) AMONG THE STUDY POPULATION 
 A total of 96 osteoarthritis patients, 65.62% (63) were in normal body weight, 
34.38% (33) were in over body weight. (Table 3, Figure 6) 
 
Table 3: BMI AMONG THE STUDY POPULATION (n = 96) 
S. No BMI NUMBER OF PATIENT PERCENTAGE 
1.  NORMAL WEIGHT 63 65.62% 
2.  OVER WEIGHT 33 34.38% 
BMI - Body Mass Index 
 
 
                   
       Figure 6: BMI AMONG THE STUDY POPULATION (n = 96) 
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6.4 COMPARISON OF EFFECT OF NSAIDs AND PREGABALIN WITH NSAIDs FOR 
OSTEOARTHRITIS AFTER TKA ON VAS 
 On VAS score, there were significant differences between baseline 5.7 ± 
0.58 and 2nd follow up was 4.42 ± 0.86 of NSAIDs alone and Pregabalin with NSAIDs 
baseline 5.6 ± 0.93 and follow up 2 2.56 ± 0.34.  P< 0.01 (Table 4, figure 7) 
Table 4: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON VAS 
S. No VAS SCORE BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  NSAIDs 
 
5.7 ± 0.58 
 
5.18 ± 0.59 
 
4.42 ± 0.86 ** 
2.  
PREGABALIN WITH 
NSAIDS 
 
5.6 ± 0.93 
 
3.97 ± 0.46 
 
 
2.56 ± 0.34 ** 
NSAIDs- Non Steroidal Anti-inflammatory Drugs, VAS – Visual Analogue Scale 
  ** p < 0.01 
 
 
 
 
 Figure 7: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON VAS 
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6.5 EFFECT OF NSAIDs DRUG FOR OSTEOARTHRITS PATIENTS AFTER TKA 
USING KOOS QUESTIONNAAIRE 
 The mean score of overall KOOS score at baseline of pain was 62.78 ± 7.92 and 
2nd follow up was 79.06 ± 6.68 which shows the significant difference among the 
participants (p˂ 0.01) (Table 5, Figure 8) 
Table 5: EFFECT OF NSAIDs FOR OSTEOARTHRITS PATIENTS AFTER TKA  
S. No PARAMETERS BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  Pain 62.78 ± 7.92 70.84 ± 6.70 79.06 ±6.68 ** 
2.  Symptoms 61.28 ± 11.72 68.36 ± 11.84 78.56 ± 9.80 ** 
3.  Activities  of Daily Living 76.42 ± 6.46 82.42 ± 5.41 88.14 ± 3.55 ** 
4.  SRF 91.3 ± 2.82 92.7 ± 3.61 93.8 ± 3.28 ** 
5.  QOL 57.7 ± 9.63 59.38 ± 8.80 64.92 ± 6.00 ** 
SRF – Sports and Recreation Function, QOL – Quality of Life        **P<0.01 
 
Figure 8: EFFECT OF NSAIDs FOR OSTEOARTHRITS PATIENTS AFTER TKA  
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6.6 EFFECT OF PREGABALIN WITH NSAIDs FOR OSTEOARTHRITIS PATIENTS 
AFTER TKA USING KOOS QUESTIONNAIRE 
 The mean score of overall KOOS pain score at baseline of pain was 67.19 ± 5.73 
and 2nd follow up was 92.73 ± 3.45 which shows the significant difference among the 
participants (p ˂ 0.01) (Table 6, Figure 9) 
Table 6: EFFECT OF PREGABALIN WITH NSAIDs FOR OSTEOARTHRITIS 
PATIENTS AFTER TKA USING KOOS QUESTIONNAIRE 
S. No PARAMETERS BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  Pain 67.19 ±  5.73 84.96 ± 4.02 92.73 ± 3.45** 
2.  Symptoms 67.87 ±  8.35 83.56 ± 6.23 89.23 ± 3.59** 
3.  Activity of Daily Living 80.21 ± 5.40 89.52 ± 2.14 94.97 ± 2.71** 
4.  SRF 92.39 ± 5.55 93.58 ± 4.03 92.60 ± 2.52** 
5.  QOL 57.5 ± 8.18 71.60 ± 3.49 81.56 ± 5.29** 
SRF – Sports and Recreation Function, QOL – Quality of Life        **P<0.01 
 
Figure 9: EFFECT OF PREGABALIN WITH NSAIDS FOR OA PATIENTS AFTER   
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6.7 COMPARISON OF EFFECT OF NSAIDs AND PREGABALIN WITH NSAIDs FOR 
OSTEOARTHRITIS AFTER TKA ON PAIN 
On pain, there were significant differences between baseline 62.78 ± 7.92 and 2nd follow 
up 79.06 ± 6.68 of NSAIDs alone and Pregabalin with NSAIDs baseline 67.19 ±  5.73 
and 2nd follow up 92.73 ± 3.45 (p< 0.01) 
Table 7: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON PAIN 
S. No GROUP BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  NSAIDs 
 
62.78 ± 7.92 
 
70.84 ± 6.70 
 
79.06 ± 6.68** 
2.  
PREGABALIN WITH 
NSAIDS 
 
67.19 ±  5.73  
 
84.96 ± 4.02 
 
92.73 ± 3.45** 
NSAIDs- Non Steroidal Anti-inflammatory Drugs, VAS – Visual Analogue Scale 
  ** p < 0.01 
 
 
Figure 10: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON PAIN 
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6.8 COMPARISON OF EFFECT OF NSAIDs AND PREGABALIN WITH NSAIDs FOR 
OSTEOARTHRITIS AFTER TKA ON SYMPTOMS 
On Symptoms, there were significant differences between baseline 61.28 ± 11.72 
and 2nd follow up 78.56 ± 9.80 of NSAIDs alone and Pregabalin with NSAIDs baseline 
67.87 ± 8.35 and 2nd follow up 89.23 ± 3.59. P< 0.01  
Table 8: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON 
SYMPTOMS 
S. No GROUP BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  NSAIDs 
 
61.28 ± 11.72 
 
68.36 ± 11.84 
 
78.56 ± 9.80 ** 
2.  
PREGABALIN WITH 
NSAIDS 
 
67.87 ±  8.35  
 
83.56 ± 6.23 
 
89.23 ± 3.59 ** 
NSAIDs- Non Steroidal Anti-inflammatory Drugs, VAS – Visual Analogue Scale 
  ** p < 0.01 
 
 
Figure 11: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON 
SYMPTOMS 
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6.9 COMPARISON OF EFFECT OF NSAIDs AND PREGABALIN WITH NSAIDs FOR 
OSTEOARTHRITIS AFTER TKA ON ACTIVITY OF DAILY LIVING 
On Activity of Daily Living, there were significant differences between baseline 
76.42 ± 6.46 and 2nd follow up 88.14 ± 3.55 of NSAIDs alone and Pregabalin with 
NSAIDs baseline 80.21 ± 5.40 and 2nd follow up 94.97 ± 2.71. P< 0.01  
Table 9: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON ADL 
S. No GROUP BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  NSAIDs 
 
76.42 ± 6.46  
 
82.42 ± 5.41 
 
 
88.14 ± 3.55 ** 
2.  
PREGABALIN WITH 
NSAIDS 
 
80.21 ± 5.40 
 
89.52 ± 2.14 
 
94.97 ± 2.71 ** 
NSAIDs- Non Steroidal Anti-inflammatory Drugs, ADL – Activities of Daily Living          
** P < 0.01 
 
Figure 12: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON ADL 
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6.10 COMPARISON OF EFFECT OF NSAIDs AND PREGABALIN WITH NSAIDs 
FOR OSTEOARTHRITIS AFTER TKA ON SPORT AND RECREATION FUNCTION 
 On Sport and Recreation Function, there were significant differences 
between baseline 91.3 ± 2.82 and 2nd follow up 93.8 ± 3.28 of NSAIDs alone and 
Pregabalin with NSAIDs baseline 92.39 ± 5.55 and 2nd follow up 92.60 ± 2.52.  P< 0.01  
Table 10: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON SRF 
S. No GROUP BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  NSAIDs 
 
91.3 ± 2.82 
 
92.7 ± 3.61 
 
93.8 ± 3.28 ** 
2.  
PREGABALIN WITH 
NSAIDS 
 
92.39 ± 5.55 
 
93.58 ± 4.03 
 
92.60 ± 2.52 * 
 
SRF – Sport and Recreation Function           ** P < 0.01  
 
Figure 13: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON SRF 
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6.11 COMPARISON QUALITY OF LIFE OF NSAIDs  Vs NSAIDs AND PREGABALIN 
GROUP  
On Quality of Life, there were significant differences between baseline 57. 7 ± 
9.63 and 2nd follow up 64.92 ± 6.00 of NSAIDs s alone and Pregabalin with NSAIDs 
baseline 57.5 ± 8.18 and 2nd follow up 81.56 ± 5.29. (P< 0.01)  
Table 11: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON QOL 
S. No GROUP BASELINE FOLLOW UP-1 FOLLOW UP-2 
1.  NSAIDs 
 
57. 7 ± 9.63 
 
59.38 ± 8.80 
 
64.92 ± 6.00 ** 
2.  
PREGABALIN WITH 
NSAIDS 
 
57.5 ± 8.18 
 
71.60 ± 3.49 
 
81.56 ± 5.29 ** 
QOL – Quality Of Life                  ** P < 0.01 
 
Figure 14: COMPARISON OF NSAIDs Vs PREGABALIN WITH NSAIDs ON QOL 
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6.12 COMPARISON OF EFFECTIVENESS OF GROUP A & B BY KOOS 
QUESTTIONNAIRE 
On KOOS score, there were significant differences between Group A & Group B 
on Pain, Symptoms, ADL and QOL but Sport and Recreation Function was not 
significant. (p < 0.01)  
Table 12: COMPARISON OF EFFECTIVENESS OF GROUP A & GROUP B  
S. No PARAMETERS GROUP A GROUP B 
1.  Pain 79.06 ±6.68  92.73 ± 3.45 ** 
2.  Symptoms 78.56 ± 9.80  89.23 ± 3.59 ** 
3.  Activities  of Daily Living 88.14 ± 3.55  94.97 ± 2.71 ** 
4.  SRF 93.8 ± 3.28  92.60 ± 2.52 
5.  QOL 64.92 ± 6.00  81.56 ± 5.29 ** 
SRF – Sport & Recreation Function,       QOL – Quality of Life.        ** p < 0.01   
   
     FIGURE 15: COMPARISON OF EFFECTIVENESS OF GROUP A & GROUP B 
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7. DISCUSSION 
 The study comprised 96 patients, out of which 46 patients were in the age 
group of 60 - 69 years. In this study, the female patients (58.34%) were more 
suffered by Osteoarthritis than male patients (41.66%). Seiji Ohtori et al 12 showed 
that mean age of 70.0±8.0 years while that of this study was 61.65 ± 7.55 years.  
 In this study majority of patients were normal weights (65.62%). As per the 
study Asokumar Buvanendran et al36 the majority of the patients were having over 
body weight. 
Comparison of Effect of NSAIDs Vs Pregabalin with NSAIDs on VAS 
 In this study totally 96 patients divided in to two different groups evaluated 
pain at movement after total knee arthroplasty. 
 Analysis of NSAIDs group showed that the mean difference VAS score was 
5.7 ± 0.58 on Baseline, 5.18 ± 0.59 on first review and 4.42 ± 0.86 on final review. 
The mean difference was statistically significant and the result was clearly indicates 
the mean decrease the pain score. (p< 0.01). 
 Analysis of Pregabalin with NSAIDs group showed that the mean difference 
VAS score was 5.6 ± 0.93 on baseline, 3.97 ± 0.46 on First review and 2.56 ± 0.34 
on second review. The mean difference was statistically significant and the result 
indicates the mean decrease the pain score. (p< 0.01). 
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NSAIDs Vs Pregabalin with NSAIDs group compared and analysed, that the 
mean difference of VAS on Baseline after TKA was not statistically significant and 
the p value was < 0.88 but on the first review the mean difference was statistically 
significant. The result indicates the mean difference of Group B was decrease the 
pain score than NSAIDs alone.  
Fei Li et al 21 resulted to indicate that the pregabalin played an important role 
in the VAS with rest at 24 hr and 48 hr, No statistically significant differences were 
found in the VAS score with rest at 72 hr and VAS on movement at 24 hr between 
the pregabalin group and the control group.  
Jokela et al 55 found that premedication with 75 or 150 mg pregabalin 
significantly reduced the VAS score for postoperative pain at 24 hr after laparoscopic 
gynaecologic surgery (p < 0.05) when compared with diazepam 5 mg. 
O. Mathiesen et al 40 have reported that pregabalin administration could 
reduce the VAS score at 24 hr compared with placebo postoperatively. 
Gianesello et al 56 showed that perioperative administration of pregabalin at a 
dose of 300 mg everyday resulted in a significant reduction in VAS scores at 48 hr 
postoperatively for patients undergoing major spinal surgery. These outcomes 
demonstrate that administration of pregabalin could reduce VAS score at 24 and 48 
h with rest after surgery. The VAS at 72 h with rest postoperatively was not 
significant in our pooled data. The decreased benefits of pregabalin on pain during 
movement could be explained by the short mean elimination half-life of pregabalin. 
No significant difference was found in VAS on movement at 24 h, and the result was 
similar to another meta-analysis of pregabalin for tonsillectomy. 
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Compared with our studies these outcomes are not significant of VAS score. 
The score of the pregabalin group was lower than that of the control group. In 
summary, preoperative administration of pregabalin could improve acute pain control 
after TKA. 
Comparison of Effect of NSAIDs Vs Pregabalin with NSAIDs on KOOS
 The perioperative administration of pregabalin to patients undergoing TKA 
was a significant decrease in the incidence of chronic neuropathic pain 3 month after 
surgery. Neuropathic pain of the operated knee can result in substantial discomfort 
and limit activities of daily living. This is the first large prospective clinical trial 
examining the incidence of chronic neuropathic pain after TKA and defining a 
strategy to prevent the development of this distressing chronic pain syndrome. 
 Fassoulaki A et al 57, the administration of gabapentin to woman undergoing 
total abdominal hysterectomy did not reduce acute postoperative pain, but there was 
a decrease in pain at I month postoperatively. 
 In our study, perioperative administration of pregabalin with NSAIDs 
pregabalin with NSAIDs group was more effective in reducing pain compared with 
NSAIDs alone group. 
 Asokumar Buvanendran et al 36 resulted that the efficacy of the perioperative 
use of pregabalin to reduce chronic neuropathic after TKA.  
 The pregabalin with NSAIDs was also effective in improved active and 
passive ROM after TKA in our study compared with NSAIDs alone group patients. 
The mean difference KOOS Score of symptoms was statically significant (p<0.01) 
and result indicates the symptoms was decreased and the knee flexion was 
improved compared with NSAIDs alone.  
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 Chiu KY et al 58 resulted that oral perioperative administration of Pregabalin 
improved knee flexion and ROM after TKA. This study is statistically significant of our 
study. It has been demonstrated that knee flexion was performed  and questioned at 
every reviews to patients of stiffness after wakening in the morning, stiffness after 
sitting or lying or resting later in the day, swelling in the knee, feeling of grinding, 
hear clicking sound from the knees and straighten and  bending knee fully and 
walking. The patients was performed well in straighten and bending knee fully. 
   It is likely that this beneficial effect on knee function after total knee 
arthroplasty was attainment of nearly full functionality in the Pregabalin with NSAIDs 
group compared with NSAIDs alone.  
 Analysis of Activities and daily living after TKA in NSAIDs Vs Pregabalin with 
NSAIDs group patients the mean difference was statistically significant (p < 0.01)  in 
final review. The result indicates the ADL was improved in Pregabalin with NSAIDs 
group compared with NSAIDs alone group.  
 The comparison and analysed of SRF of NSAIDs Vs Pregabalin with NSAIDs 
group was not statistically significant (p < 0.03) on second review. The result 
indicated the Pregabalin with NSAIDs group was not significant compared with 
NSAIDs group.   
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QUALITY OF LIFE  
 In our study that the QOL was significantly improved in Pregabalin with 
NSAIDs compared as NSAIDs plain group. 
 Compared and analysed of NSAIDs and Pregabalin with NSAIDs group was 
the mean difference of NSAIDs group the quality of life was statistically not 
significant on first Review (p < 0.0.3). but comparison of first review and second 
review the quality of life was statically significant. The result indicated the QOL was 
improved. The mean difference of Pregabalin with NSAIDs group was statistically 
significant on every review. The result indicates mean difference of QOL was 
improved. The comparison of NSAIDs group and Pregabalin with NSAIDs group the 
mean difference was statistically significant on first and second reviews. 
 Based on these findings, Pregabalin with NSAIDs group patients had less 
pain and more QOL of OA patients after total knee arthroplasty compared with 
NSAIDs group patients. 
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8. CONCLUSION 
 
 The present study showed that pregabalin with NSAIDs group was more 
effective in reducing pain after total knee arthroplasty as compared with NSAIDs 
group.  
  As per the study, pregabalin with NSAIDs group results revealed that a better 
improvement in osteoarthritis symptoms, activities of daily living and quality of life 
within short duration as compared to NSAIDS used patients. Regular patient 
counselling, maintenance of diet and exercise with good patient compliance may 
improve the quality of life of patients in day to day activities.   
However, long term treatment of pregabalin may reduce the dependence of 
analgesics and decrease the OA related neuropathic pain incidence. There by we 
can reduce the NSAIDs related side effects and improve the overall quality of life of 
OA patient after arthroplasty. 
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 NkYk;> ,e;j Ma;tpy; gq;F nfhs;tJ cq;fs; nrhe;j tpUg;gk;.  ,jpy; ve;j tpjf; fl;lhaKk; ,y;iy.  
ePq;fs; tpUg;gg;gl;lhy;> ,e;j Ma;tpd; KbTfs; cq;fSf;Fj; njhpag;gLj;jg;gLk;. 
 
 
Ma;thshpd; ifnahg;gk; : 
 
Njjp    : 
 
Ma;Tf;Fl;gLgthpd; xg;Gjy;: 
 
 ehd; ,e;j Muha;r;rpapd; Nehf;fk; kw;Wk; mjd; gad;ghl;bidg; gw;wp njspthfTk;> 
tpsf;fkhfTk; njhpag;gLj;jg; gl;Ls;Nsd;.  ,e;j Muha;r;rpapy; gq;F nfhs;sTk;> ,e;j 
Muha;r;rpapd; kUj;Jt uPjpahd Fwpg;Gfis tUk; fhyj;jpYk; cgNahfg;gLj;jpf; nfhs;sTk; KO 
kdJld; rk;kjpf;fpNwd;. 
 
Ma;Tf;Fl;gLgthpd; ngah;> Kfthp : 
 
 
 
  ifnahg;gk; : 
                     Njjp  : 
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          CASE ANALYSIS FORM  
 
 
Case No:  Department DOA DOD 
Patient  Name Age Sex 
Height 
Family History Occupation 
 
 
 
 
 
 
 
Weight 
Complaints on Admission 
 
Medical History Medication History 
Social History (Smoker, Alcoholic, Tea, Coffee, 
Tobacco, Betel Nuts, Pan etc..) 
Allergies ( Drugs, Foods and Others) 
                                                                 Physical Examination  
 Temp   BP  PR  RR  
Lab Investigation 
S. No Lab Parameter Value 
Normal 
Range 
S. No Lab Parameter Value 
Normal 
Range 
        
        
        
     Urine Analysis 
        
        
        
        
        
        
Imaging Study Report 
SWAMY VIVEKANANDHA COLLEGE OF PHARMACY 
Elayampalayam – 637205 
Department of Pharmacy Practice 
 2 of 2                   SVCP/DPP/F-02/16/01 
 
 
 
Medication Chart                                                                                                                                                               
S.No 
Brand Name 
(Generic Name) 
Dose Frequency 
Date of Administration 
          
              
              
              
              
              
              
              
              
              
              
              
              
Discharge Medication 
S.No Brand Name (Generic Name) Dose Frequency / Duration 
    
Prepared by:           Verified by: 
Final Diagnosis 
                                                                  Progress Chart 
S. No Date BP Temp PR RR Others 
       
  
 
ANNEXURE V - Visual Analogue Scale 
           
 
 
Knee Injury and Osteoarthritis Outcome Score (KOOS) 
 
 
Source: Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis 
Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 
1998 Aug;28(2):88-96. 
 
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a questionnaire designed to assess short and 
long-term patient-relevant outcomes following knee injury. The KOOS is self-administered and assesses five 
outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of 
life. The KOOS meets basic criteria of outcome measures and can be used to evaluate the course of knee 
injury and treatment outcome. KOOS is patient-administered, the format is user-friendly and it takes about 10 
minutes to fill out. 
Scoring instructions 
The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven 
items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A 
Likert scale is used and all items have five possible answer options scored from 0 (No problems) to 4 
(Extreme problems) and each of the five scores is calculated as the sum of the items included. 
Interpretation of scores 
Scores are transformed to a 0–100 scale, with zero representing extreme knee problems and 100 
representing no knee problems as common in orthopaedic scales and generic measures. Scores between 0 
and 100 represent the percentage of total possible score achieved. 
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Knee Injury and Osteoarthritis Outcome Score (KOOS) 
Pain 
P1 How often is your knee painful?  Never  Monthly  Weekly  Daily  Always 
What degree of pain have you experienced the last week when…? 
P2  Twisting/pivoting on your knee  None  Mild  Moderate  Severe  Extreme 
P3  Straightening knee fully  None  Mild  Moderate  Severe  Extreme 
P4  Bending knee fully  None  Mild  Moderate  Severe  Extreme 
P5  Walking on flat surface  None  Mild  Moderate  Severe  Extreme 
P6  Going up or down stairs  None  Mild  Moderate  Severe  Extreme 
P7  At night while in bed  None  Mild  Moderate  Severe  Extreme 
P8  Sitting or lying  None  Mild  Moderate  Severe  Extreme 
P9  Standing upright  None  Mild  Moderate  Severe  Extreme 
Symptoms 
Sy1  How severe is your knee 
 stiffness after first wakening in 
 the morning? 
 None  Mild  Moderate  Severe  Extreme 
Sy2  How severe is your knee 
 stiffness after sitting, lying, or 
 resting later in the day? 
 None  Mild  Moderate  Severe  Extreme 
Sy3  Do you have swelling in your 
 knee? 
 Never  Rarely  Sometimes  Often  Always 
Sy4  Do you feel grinding, hear 
 clicking or any other type of 
 noise when your knee moves? 
 Never  Rarely  Sometimes  Often  Always 
Sy5  Does your knee catch or hang 
 up when moving? 
 Never  Rarely  Sometimes  Often  Always 
Sy6  Can you straighten your knee 
 fully? 
 Always  Often  Sometimes  Rarely  Never 
Sy7 Can you bend your knee fully?  Always  Often  Sometimes  Rarely  Never 
 
 
 
Knee Injury and Osteoarthritis Outcome Score (KOOS)  
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Activities of daily living 
What difficulty have you experienced the last week…? 
A1 Descending   None  Mild  Moderate  Severe  Extreme 
A2  Ascending stairs  None  Mild  Moderate  Severe  Extreme 
A3  Rising from sitting  None  Mild  Moderate  Severe  Extreme 
A4  Standing  None  Mild  Moderate  Severe  Extreme 
A5  Bending to floor/picking up an 
 object 
 None  Mild  Moderate  Severe  Extreme 
A6  Walking on flat surface  None  Mild  Moderate  Severe  Extreme 
A7  Getting in/out of car  None  Mild  Moderate  Severe  Extreme 
A8  Going shopping  None  Mild  Moderate  Severe  Extreme 
A9  Putting on socks/stockings  None  Mild  Moderate  Severe  Extreme 
A10  Rising from bed  None  Mild  Moderate  Severe  Extreme 
A11  Taking off socks/stockings  None  Mild  Moderate  Severe  Extreme 
A12  Lying in bed (turning over, 
 maintaining knee position) 
 None  Mild  Moderate  Severe  Extreme 
A13  Getting in/out of bath  None  Mild  Moderate  Severe  Extreme 
A14  Sitting  None  Mild  Moderate  Severe  Extreme 
A15  Getting on/off toilet  None  Mild  Moderate  Severe  Extreme 
A16  Heavy domestic duties 
 (shovelling, scrubbing floors, 
 etc) 
 None  Mild  Moderate  Severe  Extreme 
A17  Light domestic duties (cooking, 
 dusting, etc) 
 None  Mild  Moderate  Severe  Extreme 
Sport and recreation function 
What difficulty have you experienced the last week…? 
Sp1  Squatting  None  Mild  Moderate  Severe  Extreme 
Sp2  Running  None  Mild  Moderate  Severe  Extreme 
Sp3  Jumping  None  Mild  Moderate  Severe  Extreme 
Sp4  Turning/twisting on your injured 
 knee 
 None  Mild  Moderate  Severe  Extreme 
Sp5  Kneeling  None  Mild  Moderate  Severe  Extreme 
Knee Injury and Osteoarthritis Outcome Score (KOOS)  
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Knee-related quality of life 
 
Q1  How often are you aware of your 
 knee problems? 
 Never  Monthly  Weekly  Daily  Always 
Q2  Have you modified your lifestyle 
 to avoid potentially damaging 
 activities to your knee? 
 Not at all  Mildly  Moderately  Severely  Totally 
Q3  How troubled are you with lack 
 of confidence in your knee? 
 Not at all  Mildly  Moderately  Severely  Totally 
Q4  In general, how much difficulty 
 do you have with your knee? 
 None  Mild  Moderate  Severe  Extreme 
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